BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17949783)

  • 1. Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification.
    Elliott DD; Sherman SI; Busaidy NL; Williams MD; Santarpia L; Clayman GL; El-Naggar AK
    Hum Pathol; 2008 Jan; 39(1):15-20. PubMed ID: 17949783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
    Williams MD; Roberts D; Blumenschein GR; Temam S; Kies MS; Rosenthal DI; Weber RS; El-Naggar AK
    Am J Surg Pathol; 2007 Nov; 31(11):1645-52. PubMed ID: 18059220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor as a novel therapeutic target in anaplastic thyroid carcinomas.
    Ensinger C; Spizzo G; Moser P; Tschoerner I; Prommegger R; Gabriel M; Mikuz G; Schmid KW
    Ann N Y Acad Sci; 2004 Dec; 1030():69-77. PubMed ID: 15659782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.
    Walker F; Abramowitz L; Benabderrahmane D; Duval X; Descatoire V; Hénin D; Lehy T; Aparicio T
    Hum Pathol; 2009 Nov; 40(11):1517-27. PubMed ID: 19716155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.
    Wiseman SM; Masoudi H; Niblock P; Turbin D; Rajput A; Hay J; Filipenko D; Huntsman D; Gilks B
    Am J Surg; 2006 May; 191(5):581-7. PubMed ID: 16647341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer.
    Chakravarty G; Santillan AA; Galer C; Adams HP; El-Naggar AK; Jasser SA; Mohsin S; Mondal D; Clayman GL; Myers JN
    Exp Biol Med (Maywood); 2009 Apr; 234(4):372-86. PubMed ID: 19176870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.
    Merrick DT; Kittelson J; Winterhalder R; Kotantoulas G; Ingeberg S; Keith RL; Kennedy TC; Miller YE; Franklin WA; Hirsch FR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2281-8. PubMed ID: 16609045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB-receptors expression and survival in breast carcinoma: a 15-year follow-up study.
    Bianchi S; Palli D; Falchetti M; Saieva C; Masala G; Mancini B; Lupi R; Noviello C; Omerovic J; Paglierani M; Vezzosi V; Alimandi M; Mariani-Costantini R; Ottini L
    J Cell Physiol; 2006 Mar; 206(3):702-8. PubMed ID: 16245316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas.
    Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
    Cancer Res; 1996 Mar; 56(6):1184-8. PubMed ID: 8640794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the GLUT1 glucose transporter, p63 and p53 in thyroid carcinomas.
    Kim YW; Do IG; Park YK
    Pathol Res Pract; 2006; 202(11):759-65. PubMed ID: 17029809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
    Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
    Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of retinoblastoma tumor suppressor gene protein, epidermal growth factor receptor, and c-erbB-2 oncoprotein in primary vaginal carcinomas.
    Skomedal H; Kristensen G; Holm R
    Gynecol Oncol; 1995 Dec; 59(3):379-83. PubMed ID: 8522259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment.
    Wiseman SM; Masoudi H; Niblock P; Turbin D; Rajput A; Hay J; Bugis S; Filipenko D; Huntsman D; Gilks B
    Ann Surg Oncol; 2007 Feb; 14(2):719-29. PubMed ID: 17115102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.
    Sarkaria IS; Zakowski MF; Pham D; Hezel M; Ebright MI; Chuai S; Venkatraman ES; Kris MG; Rusch VW; Singh B
    Ann Thorac Surg; 2008 Jan; 85(1):216-23. PubMed ID: 18154814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal immunohistochemical expression of sodium/iodide symporter and hexokinase I in primary thyroid tumors with synchronous cervical metastasis.
    Jung YH; Hah JH; Sung MW; Kim KH; Cho SY; Jeon YK
    Laryngoscope; 2009 Mar; 119(3):541-8. PubMed ID: 19235753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER2 and EGFR expression in cutaneous spindle squamous cell carcinoma.
    Schlauder SM; Calder KB; Moody P; Morgan MB
    Am J Dermatopathol; 2007 Dec; 29(6):559-63. PubMed ID: 18032952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
    Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.
    Matsubara J; Yamada Y; Hirashima Y; Takahari D; Okita NT; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
    Clin Cancer Res; 2008 May; 14(10):3022-9. PubMed ID: 18483367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor expression in anal canal carcinoma.
    Lê LH; Chetty R; Moore MJ
    Am J Clin Pathol; 2005 Jul; 124(1):20-3. PubMed ID: 15923158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.